Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 08:57 am Sale |
2024-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
Flynn James E | 3,133,011 2.630% |
-3,096,623 (-49.71%) |
Filing History |
| 2024-11-14 09:55 am Sale |
2024-09-30 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
Flynn James E | 6,229,634 5.220% |
-2,659,267 (-29.92%) |
Filing History |
| 2024-11-08 5:31 pm Unchanged |
2024-09-30 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
BLACKROCK INC BLK |
19,016,873 16.000% |
0 (Unchanged) |
Filing History |
| 2024-10-18 3:31 pm Purchase |
2024-09-30 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
BLACKROCK INC BLK |
19,016,873 16.000% |
3,195,472 (+20.20%) |
Filing History |
| 2024-10-17 12:14 pm Sale |
2024-09-30 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
STATE STREET CORP STT |
5,685,330 4.800% |
-1,102,002 (-16.24%) |
Filing History |
| 2024-02-13 5:00 pm Purchase |
2023-12-29 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
The Vanguard Group | 7,120,417 6.680% |
351,676 (+5.20%) |
Filing History |
| 2024-02-12 5:31 pm Purchase |
2023-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
Flynn James E | 8,888,901 8.340% |
3,004,453 (+51.06%) |
Filing History |
| 2024-01-25 10:09 am Sale |
2023-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
STATE STREET CORP STT |
6,787,332 6.370% |
-1,085,982 (-13.79%) |
Filing History |
| 2024-01-22 3:52 pm Purchase |
2023-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
BLACKROCK INC BLK |
15,821,401 14.800% |
131,075 (+0.84%) |
Filing History |
| 2023-02-14 12:27 pm Sale |
2022-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
Armistice Capital, LLC | 0 0.000% |
-9,572,000 (Position Closed) |
Filing History |
| 2023-02-10 09:28 am Sale |
2022-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
Flynn James E | 5,884,448 5.650% |
-176,043 (-2.90%) |
Filing History |
| 2023-02-09 11:12 am Purchase |
2022-12-30 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
The Vanguard Group | 6,768,741 6.500% |
1,932,428 (+39.96%) |
Filing History |
| 2023-02-08 10:44 am Purchase |
2022-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
STATE STREET CORP STT |
7,873,314 7.570% |
2,822,325 (+55.88%) |
Filing History |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
BLACKROCK INC BLK |
15,690,326 15.100% |
0 (Unchanged) |
Filing History |
| 2023-01-20 09:43 am Purchase |
2022-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
BLACKROCK INC BLK |
15,690,326 15.100% |
421,395 (+2.76%) |
Filing History |
| 2022-11-14 4:45 pm Purchase |
2022-11-04 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
Flynn James E | 6,060,491 5.820% |
6,060,491 (New Position) |
Filing History |
| 2022-10-07 2:58 pm Purchase |
2022-09-30 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
BLACKROCK INC BLK |
15,268,931 14.900% |
7,584,233 (+98.69%) |
Filing History |
| 2022-02-14 6:28 pm Sale |
2021-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
Armistice Capital, LLC | 9,572,000 9.300% |
-428,000 (-4.28%) |
Filing History |
| 2022-02-09 3:33 pm Sale |
2021-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
The Vanguard Group | 4,836,313 4.690% |
-934,766 (-16.20%) |
Filing History |
| 2022-02-09 12:23 pm Sale |
2021-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX |
STATE STREET CORP STT |
5,050,989 4.900% |
-1,062,941 (-17.39%) |
Filing History |